pancreatic cancer

Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
CP Wire
Wed, 05/23/18 - 10:30 pm
pancreatic cancer
diagnostics
biomarkers
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
Wed, 05/23/18 - 01:06 pm
pancreatic cancer
Pancreatic cancer combo sees high survival rates in ChemoCentryx PhIb data
Endpoints
Tue, 01/23/18 - 02:48 pm
pancreatic cancer
ChemoCentryx
CCX872
Novocure wins FDA nod for pivotal pancreatic cancer trial
Drug Delivery Business News
Mon, 12/18/17 - 11:24 am
Novocure
FDA
pancreatic cancer
TTFields
A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It
Forbes
Mon, 09/11/17 - 09:16 am
pancreatic cancer
PARP inhibitors
Clovis Oncology
Rubraca
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
Thu, 07/13/17 - 09:03 am
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
OncoMed's pancreatic cancer drug fails mid-stage study
Yahoo/Reuters
Mon, 04/10/17 - 11:00 am
OncoMed
pancreatic cancer
clinical trials
Celgene
Abraxane
demcizumab
France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal
Yahoo/Reuters
Mon, 01/9/17 - 09:54 am
Ipsen
France
Merrimack Pharmaceuticals
pancreatic cancer
Onivyde
Halozyme Cancer Drug Does Well in Phase 2
Investopedia
Fri, 01/6/17 - 10:13 am
Halozyme
pancreatic cancer
clinical trials
PEGPH20
Eli Lilly
Celgene
gemcitabine
Abraxane
How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment
Market Realist
Fri, 09/2/16 - 11:24 am
Pfizer
Ibrance
breast cancer
head and neck cancer
lung cancer
pancreatic cancer
Momenta’s failed pancreatic cancer drug is given a midnight funeral
Endpoints
Fri, 09/2/16 - 09:39 am
Momenta Pharmaceuticals
pancreatic cancer
necuparanib
3 Shocking Biotech Flops of 2016 So Far
Motley Fool
Fri, 07/8/16 - 11:01 am
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
Clovis Oncology Presents Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer and Pancreatic Cancer at 2016 ASCO Annual Meeting
Yahoo
Mon, 06/6/16 - 11:04 am
Clovis Oncology
rucaparib
ovarian cancer
pancreatic cancer
ASCO 2016
Aduro Biotech Pancreatic Cancer Immunotherapy Fails Mid-Stage Study
TheStreet.com
Mon, 05/16/16 - 11:09 am
Aduro BioTech
pancreatic cancer
clinical trials
CRS-207
NewLink Genetics writes off pancreatic cancer immunotherapy after phase 3 failure
BioPharma Dive
Tue, 05/10/16 - 10:33 am
NewLink Genetics
pancreatic cancer
algenpantucel-L
​Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Bizjournals.com
Tue, 05/3/16 - 10:09 am
Merrimack Pharmaceuticals
Onivyde
pancreatic cancer
Oxigene's pancreatic cancer treatments granted orphan drug status in Europe
Marketwatch
Sat, 03/26/16 - 01:01 pm
Oxigene
pancreatic cancer
orphan drugs
CA4P
Gilead Ends a Phase 2 Study for Antibody
WSJ Online
Wed, 01/6/16 - 08:00 pm
Gilead Sciences
simtuzumab
pancreatic cancer
NewLink Genetics Vaccine May Improve How We Treat Pancreatic Cancer
Motley Fool
Wed, 12/23/15 - 09:52 pm
vaccines
pancreatic cancer
NewLink Genetics
algenpantucel-L
clinical trials
Bristol-Myers Squibb's Opdivo May Change How We Treat Pancreatic Cancer
Motley Fool
Sun, 11/29/15 - 12:36 pm
Bristol-Myers Squibb
Opdivo
pancreatic cancer

Pages